Abstract
Human rhinoviruses (HRV) are the major etiological agents of the common cold and asthma exacerbations, with significant worldwide health and economic impact. Although large-scale population vaccination has proved successful in limiting or even eradicating many viruses, the more than 100 distinct serotypes mean that conventional vaccination is not a feasible strategy to combat HRV. An alternative strategy is to target conserved viral proteins such as the HRV proteases, 2Apro and 3Cpro, the focus of this review. Necessary for host cell shutoff, virus replication, and pathogenesis, 2Apro and 3Cpro are clearly viable drug targets, and indeed, 3Cpro has been successfully targeted for treating the common cold in experimental infection. 2Apro and 3Cpro are crucial for virus replication due to their role in polyprotein processing as well as cleavage of key cellular proteins to inhibit cellular transcription and translation. Intriguingly, the action of the HRV proteases also disrupts nucleocytoplasmic trafficking, contributing to HRV cytopathic effects. Improved understanding of the protease-cell interactions should enable new therapeutic approaches to be identified for drug development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gwaltney JM (1975) Yale J Biol Med 48:17–45
Skern T, Sommergruber W, Blaas D, Gruendler P, Fraundorfer F, Pieler C, Fogy I, Keuchler E (1985) Nucleic Acid Res 13:2111–2126
Arruda E, PitkÃranta A, Witek TJ, Doyle CA, Hayden FG (1997) J Clin Microbiol 35:2864–2868
Pitkaranta A, Hayden FG (1998) Ann Med 30:529–537
Nicholson KG, Kent J, Hammersley V, Cancio E (1997) Br Med J 315:1060–1064
Message SD, Laza-Stanca V, Mallia P, Parker HL, Zhu J, Kebadze T, Contoli M, Sanderson G, Kon OM, Papi A, Jeffery PK, Stanciu LA, Johnston SL (2008) Proc Natl Acad Sci 105:13562–13567
Nicholson KG, Kent J, Ireland DC (1993) BMJ 307:982–986
Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O’Toole S, Myint SH, Tyrrell DAJ, Holgate ST (1995) Br Med J 310:1225–1229
Fox JP (1976) Am J Epidemiol 103:345–354
Cooney MK, Kenny GE (1970) J Immunol 105:531–533
Cooney MK, Fox JP, Kenny GE (1982) Infect Immun 37:642–647
Rueckert RR (1996) In: Fields BN, Knipe DM, Howley PM (eds) Fields virology, 3rd edn, Lippincott-Raven, Philadelphia, PA, p 609–654
Stanway G, Hughes PJ, Mountford RC, Minor PD, Almond JW (1984) Nucleic Acid Res 12:7859–7875
Knott JA, Orr DC, Montgomery DS, Sullivan CA, Weston A (1989) Eur J Biochem 182:547–555
Bazan JF, Fletterick RJ (1988) Proc Natl Acad Sci U S A 85:7872–7876
Savolainen C, Mulders MN, Hovi T (2002) Virus Res 85:41–46
Lau SK, Yip CC, Tsoi HW, Lee RA, So LY, Lau YL, Chan KH, Woo PC, Yuen KY (2007) J Clin Microbiol 45:3655–3664
Binford SL, Maldonado F, Brothers MA, Weady PT, Zalman LS, Meador JW 3rd, Matthews DA, Patick AK (2005) Antimicrob Agents Chemother 49:619–626
Cordingley MG, Callahan PL, Sardana VV, Garsky VM, Colonno RJ (1990) J Biol Chem 265:9062–9065
Matthews DA, Dragovich PS, Webber SE, Fuhrman SA, Patick AK, Zalman LS, Henrickson TF, Love RA, Prins TJ, Marakovits JT, Zhou R, Tikhe J, Ford CE, Meador JW, Ferre RA, Brown EL, Binford SL, Brothers MA, DeLisle DM, Worland ST (1999) Proc Natl Acad Sci U S A 96:11000–11007
Toyoda H, Nicklin MJH, Murray MG, Anderson CW, Dunn JJ, Studier FW, Wimmer E (1986) Cell 45:761–770
Sommergruber W, Zorn M, Blaas D, Fessl F, Volkmann P, Maurer-Fogy I, Pallai P, Merluzzi V, Matteo M, Skern T, Kuechler E (1989) Virology 169:68–77
Kräusslich HG, Wimmer E (1988) Annu Rev Biochem 57:701–754
Kay J, Dunn BM (1990) Biochim Biophys Acta 1048:1–18
Lawson MA, Semler BL (1990) Curr Top Microbiol Immunol 161:49–87
Dragovich PS, Zhou R, Skalitzky DJ, Fuhrman SA, Patick AK, Ford CE, Meador Iii JW, Worland ST (1999) Bioorg Med Chem 7:589–598
Patick AK, Binford SL, Brothers MA, Jackson RL, Ford CE, Diem MD, Maldonado F, Dragovich PS, Zhou R, Prins TJ, Fuhrman SA, Meador JW, Zalman LS, Matthews DA, Worland ST (1999) Antimicrob Agents Chemother 43:2444–2450
Hayden FG, Turner RB, Gwaltney JM, Chi-Burris K, Gersten M, Hsyu P, Patick AK, Smith GJ, Zalman LS (2003) Antimicrob Agents Chemother 47:3907–3916
Patick AK, Brothers MA, Maldonado F, Binford S, Maldonado O, Fuhrman S, Petersen A, Smith GJ 3rd, Zalman LS, Burns-Naas LA, Tran JQ (2005) Antimicrob Agents Chemother 49:2267–2275
Orr DC, Long AC, Kay J, Dunn BM, Cameron JM (1989) J Gen Virol 70:2931–2942
Cheah KC, Leong LE, Porter AG (1990) J Biol Chem 265:7180–7187
Petersen JF, Cherney MM, Liebig HD, Skern T, Kuechler E, James MN (1999) EMBO J 18:5463–5475
Seipelt J, Guarne A, Bergmann E, James M, Sommergruber W, Fita I, Skern T (1999) Virus Res 62:159–168
Neurath H (1984) Science 224:350–357
Cordingley MG, Register RB, Callahan PL, Garsky VM, Colonno RJ (1989) J Virol 63:5037–5045
Ypma-Wong MF, Dewalt PG, Johnson VH, Lamb JG, Semler BL (1988) Virology 166:265–270
Leong LE, Walker PA, Porter AG (1993) J Biol Chem 268:25735–25739
Skern T, Sommergruber W, Auer H, Volkmann P, Zorn M, Liebig HD, Fessl F, Blaas D, Kuechler E (1991) Virology 181:46–54
Hellen CU, Lee CK, Wimmer E (1992) J Virol 66:3330–3338
Amineva SP, Aminev AG, Palmenberg AC, Gern JE (2004) J Gen Virol 85:2969–2979
Sipos K, Olson MOJ (1991) Biochem Biophys Res Commun 177:673–678
Szebeni A, Olson MOJ (1999) Protein Sci 8:905–912
Amineva SP, Aminev AG, Gern JE, Palmenberg AC (2011) J Gen Virol 92:2549–2557
Barral PM, Morrison JM, Drahos J, Gupta P, Sarkar D, Fisher PB, Racaniello VR (2007) J Virol 81:3677–3684
Barral PM, Sarkar D, Fisher PB, Racaniello VR (2009) Virology 391:171–176
Barral PM, Sarkar D, Su Z-Z, Barber GN, DeSalle R, Racaniello VR, Fisher PB (2009) Pharmacol Therapeut 124:219–234
Joachims M, Harris KS, Etchison D (1995) Virology 211:451–461
Lin J-Y, Chen T-C, Weng K-F, Chang S-C, Chen L-L, Shih S-R (2009) J Biomed Sci 16:103
Clark ME, Lieberman PM, Berk AJ, Dasgupta A (1993) Mol Cell Biol 13:1232–1237
Falk MM, Grigera PR, Bergmann IE, Zibert A, Multhaup G, Beck E (1990) J Virol 64:748–756
Clark ME, HÃmmerle T, Wimmer E, Dasgupta A (1991) EMBO J 10:2941–2947
Funkhouser AW, Kang J, Tan A, Li J, Zhou L, Abe MK, Solway J, Hershenson MB (2004) Pediatr Res 55:13–18
Kim J, Sanders SP, Siekierski ES, Casolaro V, Proud D (2000) J Immunol 165:3384–3392
Schroth MK, Grimm E, Frindt P, Galagan DM, Konno SI, Love R, Gern JE (1999) Am J Respir Cell Mol Biol 20:1220–1228
Chase AJ, Semler BL (2012) Future Virol 7:179–191
Etchison D, Fout S (1985) J Virol 54:634–638
Lloyd RE, Grubman MJ, Ehrenfeld E (1988) J Virol 62:4216–4223
Sonenberg N, Morgan MA, Merrick WC, Shatkin AJ (1978) Proc Natl Acad Sci 75:4843–4847
Ray BK, Lawson TG, Kramer JC, Cladaras MH, Grifo JA, Abramson RD, Merrick WC, Thach RE (1985) J Biol Chem 260:7651–7658
Rozen F, Edery I, Meerovitch K, Dever TE, Merrick WC, Sonenberg N (1990) Mol Cell Biol 10:1134–1144
Lamphear BJ, Yan R, Yang F, Waters D, Liebig HD, Klump H, Kuechler E, Skern T, Rhoads RE (1993) J Biol Chem 268:19200–19203
Lamphear BJ, Kirchweger R, Skern T, Rhoads RE (1995) J Biol Chem 270:21975–21983
Andino R, Rieckhof GE, Baltimore D (1990) Cell 63:369–380
Andino R, Rieckhof GE, Achacoso PL, Baltimore D (1993) EMBO J 12:3587–3598
Parsley TB, Towner JS, Blyn LB, Ehrenfeld E, Semler BL (1997) RNA 3:1124–1134
Gamarnik AV, Andino R (1998) Genes Dev 12:2293–2304
Perera R, Daijogo S, Walter BL, Nguyen JHC, Semler BL (2007) J Virol 81:8919–8932
Kozlov G, Trempe J-F, Khaleghpour K, Kahvejian A, Ekiel I, Gehring K (2001) Proc Natl Acad Sci 98:4409–4413
Jacobson A, Favreau M (1983) Nucleic Acids Res 11:6353–6368
Park N, Katikaneni P, Skern T, Gustin KE (2008) J Virol 82:1647–1655
Watters K, Palmenberg AC (2011) J Virol 85:10874–10883
Gustin KE, Sarnow P (2002) J Virol 76:8787–8796
Fitzgerald KD, Chase AJ, Cathcart AL, Tran GP, Semler BL (2013) J Virol 87:2390–2400
Bizzintino J, Lee WM, Laing IA, Vang F, Pappas T, Zhang G, Martin AC, Khoo SK, Cox DW, Geelhoed GC, McMinn PC, Goldblatt J, Gern JE, Le SouÃf PN (2011) Eur Res J 37: 1037–1042
Walker EJ, Younessi P, Fulcher AJ, McCuaig R, Thomas BJ, Bardin PG, Jans DA, Ghildyal R (2013) PLoS One 8:e71316
Ghildyal R, Jordan B, Li D, Dagher H, Bardin PG, Gern JE, Jans DA (2009) J Virol 83:7349–7352
Singh M, Lee S-H, Porter P, Xu C, Ohno A, Atmar RL, Greenberg SB, Bandi V, Gern J, Amineva S, Aminev A, Skern T, Smithwick P, Perusich S, Barrow N, Roberts L, Corry DB, Kheradmand F (2010) J Allergy Clin Immunol 125:1369e2–1378e2
Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, Marlor CW, Kamarck ME, McClelland A (1989) Cell 56:839–847
Hofer F, Gruenberger M, Kowalski H, Machat H, Huettinger M, Kuechler E, Blaas D (1994) Proc Natl Acad Sci U S A 91:1839–1842
Bernstein HD, Sonenberg N Baltimore D (1985) Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Molecular and Cellular Biology. 5(11):2913–2923
Park N, Skern T, Gustin KE (2010) Specific Cleavage of the Nuclear Pore Complex Protein Nup62 by a Viral Protease. Journal of Biological Chemistry 285(37): 28796–28805
Acknowledgements
This research was supported by National Health and Medical Research Council (Australia) project (APP545844 and APP1027312) grants and SPRF1 fellowship (to DAJ; APP1002486).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Jensen, L.M., Walker, E.J., Jans, D.A., Ghildyal, R. (2015). Proteases of Human Rhinovirus: Role in Infection. In: Jans, D., Ghildyal, R. (eds) Rhinoviruses. Methods in Molecular Biology, vol 1221. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1571-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1571-2_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1570-5
Online ISBN: 978-1-4939-1571-2
eBook Packages: Springer Protocols